Bill Alpert on Muck Rack

Bill Alpert

Verified
New York
As seen in: Barron's, MSN, Yahoo News, Yahoo News New Zealand, Yahoo Singapore, Yahoo Finance, Yahoo Finance Singapore, MarketWatch, Flipboard, Mint, Nasdaq and
Bill Alpert is a Senior Writer at Barron’s, where since 1984 he has published nerdy feature stories, columns and investigative projects of use to investors.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bill

Contact Bill, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cancer Blood Screen SPAC Merger Is Delayed by Test’s Results

|
By Bill Alpert Verified
| Yahoo Verified
Cancer Blood Screen SPAC Merger Is Delayed by Test’s Results Thu, July 9, 2026 at 8:48 PM UTC Add Yahoo as a preferred source to see more of our stories on Google. Cancer Blood Screen SPAC Merger Is Delayed by Test’s Results Thursday was the day set for shareholders to approve the merger of special-purpose acquisition company Perceptive Capital Solutions with cancer screening firm Freenome.
Open in Who Shared View Duplicates (2) Issue with article?

KKR, Blue Owl, and Blackstone tumble. Why private-market jitters are back and hitting the stocks.

|
By Bill Alpert Verified
| MSN Verified
; ; Continue reading More for You Continue reading More for You
Open in Who Shared View Duplicates (688) Issue with article?

Microsoft Cares About Your Privacy More bad news at KKR's private credit fund

|
By Bill Alpert Verified
| MSN Verified
Bill Alpert The private credit fund that's been a black eye for KKR looked even worse with Monday's report of its latest results. The value of FS KKR Capital Corp. loan portfolio declined 10% from December to March, ending at $18.83 a share. Continued struggles at some of the fund's borrowers and new repayment problems at other borrowers drove the decline.
Open in Who Shared Issue with article?
See all 2,078 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified